German tech M&A market strong; but companies ignore tech-specific legal requirements at their peril.

13 Nov 2014 | 02:56 pm | 1 min. read

In a survey recently undertaken by international law firm Pinsent Masons into the German Tech M&A market, there are clear signs that we are in a seller's market.

The research, which seeks to establish the 'market standard' for tech M&A in the German market, shows that of the sample deals, some 40% used a 'locked box' mechanism to fix the price at an early stage of the deal – this is usually only achievable when the seller is in a very strong position. Closing accounts which ultimately determines the 'correct' purchase price at a later stage, accounted for 50% of deals. Nonetheless, in a less seller-friendly market, the distribution between these two purchase price mechanisms would be clearly skewed towards closing accounts.

Interestingly, companies undertaking M&A in the technology sector did not commonly seek out legal advisors with strong technology-sector experience. While some 75% of corporate finance advisers were appointed on the strength of their technology-sector knowledge, only 46% of lawyers appointed were sought out for their sector experience. This relative lack of technology experience among law firms appeared to manifest itself in the way transactions were undertaken. Safeguards around intellectual property, for example, typically have a disproportionate importance in technology deals. However, only 31% of deals in the survey actually had an IP-specific workstream. Yet of the technology-related risks that were identified in the same survey, some 67% of these were IP-related. It would appear then that there is a significant risk that a large number of IP risks in technology transactions may be going unidentified if so few deals are properly assessing IP as part of the due diligence.

Rainer Kreifels, Head of Pinsent Masons in Germany said: "The tech M&A market in Germany is clearly very healthy and sellers appear to be in a strong position. But our survey shows that deal-makers do need to be aware of the technology-specific risks to their deals to ensure a successful long-term legacy."

A full version of the report may be downloaded here.

Key Contacts

Rainer Kreifels

Rainer Kreifels

Rechtsanwalt, Partner, Head of Germany

View Profile

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons appointed to UK Government Trade Law Panel

Multinational law firm Pinsent Masons has been appointed to the UK Government's new Trade Law Panel in an international consortium with BakerHostetler in the USA, and Fasken in Canada, to advise on international trade law disputes.

Pinsent Masons advises on 5G Create - the £28m government funded 5G test projects

Multinational law firm Pinsent Masons has advised the Department for Digital, Culture, Media and Sport (DCMS) on its innovative joint £28m investment in 5G test projects to showcase the capability of 5G technology across a range of industries and identify commercially sustainable long-term use cases.

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts